Publication:
Alzheimer's disease and vascular biology - A focus on the procoagulant state.

dc.contributor.authorCasquero-Veiga, Marta
dc.contributor.authorCeron, Carlos
dc.contributor.authorCortes-Canteli, Marta
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderUnión Europea. Comisión Europea. NextGenerationEU
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España)
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.contributor.funderFundación ProCNIC
dc.date.accessioned2025-07-23T13:49:47Z
dc.date.available2025-07-23T13:49:47Z
dc.date.issued2025-05-09
dc.description.abstractAlzheimer's disease (AD) is characterized by a multifactorial pathophysiology. Beyond its classical hallmarks, growing evidence highlights vascular contributions, including hemostatic dysregulation and a prothrombotic state in AD. This review focuses on recent findings concerning two key blood clot components-fibrin(ogen) and platelets-and their roles in AD pathology, including fibrinogen's abnormal accumulation in the AD brain, its interaction with amyloid-β, together with the associated impacts on clot stability, vascular occlusion, and neuroinflammation; and the potential switch of platelets along the AD continuum from protective to deleterious. This review provides an update on the interplay between vascular dysfunction and AD, underscoring the need for comprehensive integrative research to address AD's complexity and advocating for personalized approaches to tackle this multifaceted disorder.
dc.description.peerreviewed
dc.description.tableofcontentsThis work was funded by grant JPND2020-568-025, an EU Joint Programme-Neurodegenerative Disease Research (JPND) project supported through the Spanish National Institute of Health Carlos III (ISCIII) under the aegis of JPND (project AC20/00077, cofunded by the European Regional Development Fund “A way to make Europe”); and by grant CNS2023- 144316 funded by the MCIN/AEI/10.13039/501100011033 and by the EU NextGenerationEU/PRTR. CNIC is a Severo Ochoa Center of Excellence (CEX2020-001041-S) and is supported by the ISCIII, the Spanish Ministry for Science and Innovation, and Pro-CNIC Foundation. MCV is supported by a BrightFocus Foundation Postdoctoral Fellowship in Alzheimer’s Disease Research (A2023012F), and grant JDC2022-048922-I funded by MCIN/AEI/10.13039/ 501100011033 and the EU NextGenerationEU/PRTR.
dc.identifier.citationCurr Opin Cell Biol. 2025 May 9:95:102528.
dc.identifier.journalCurrent Opinion in Cell Biology
dc.identifier.pubmedID40347710
dc.identifier.urihttps://hdl.handle.net/20.500.12105/26844
dc.language.isoeng
dc.publisherElsevier
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/AC20/00077
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CNS2023-144316
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/MCIN/AEI/10.13039/501100011033
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/CEX2020-001041-S
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/A2023012F
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/JDC2022-048922-I
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/MCIN/AEI/10.13039/501100011033
dc.relation.publisherversionhttps://doi.org/10.1016/j.ceb.2025.102528
dc.repisalud.institucionCNIC
dc.repisalud.orgCNICCNIC::Grupos de investigación::Imagen Cardiovascular y Estudios Poblacionales
dc.rights.accessRightsopen access
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleAlzheimer's disease and vascular biology - A focus on the procoagulant state.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Alzheimer's disease and vascular biology_Curr Opin Cell Biol_2025.pdf
Size:
2.56 MB
Format:
Adobe Portable Document Format